Cite
DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 Mpro inhibitors.
MLA
Chamakuri, Srinivas, et al. “DNA-Encoded Chemistry Technology Yields Expedient Access to SARS-CoV-2 Mpro Inhibitors.” Proceedings of the National Academy of Sciences of the United States of America, vol. 118, no. 36, Sept. 2021, pp. 1–8. EBSCOhost, https://doi.org/10.1073/pnas.2111172118.
APA
Chamakuri, S., Shuo Lu, Ucisik, M. N., Bohren, K. M., Ying-Chu Chen, Huang-Chi Du, Faver, J. C., Jimmidi, R., Feng Li, Jian-Yuan Li, Nyshadham, P., Palmer, S. S., Pollet, J., Xuan Qin, Ronca, S. E., Sankaran, B., Sharma, K. L., Zhi Tan, Versteeg, L., & Zhifeng Yu. (2021). DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 Mpro inhibitors. Proceedings of the National Academy of Sciences of the United States of America, 118(36), 1–8. https://doi.org/10.1073/pnas.2111172118
Chicago
Chamakuri, Srinivas, Shuo Lu, Melek Nihan Ucisik, Kurt M. Bohren, Ying-Chu Chen, Huang-Chi Du, John C. Faver, et al. 2021. “DNA-Encoded Chemistry Technology Yields Expedient Access to SARS-CoV-2 Mpro Inhibitors.” Proceedings of the National Academy of Sciences of the United States of America 118 (36): 1–8. doi:10.1073/pnas.2111172118.